Baguio will go ahead with AstraZeneca use
Investigation on the reported side effects of the vaccine is still ongoing
BAGUIO CITY — The city will push through with its plan to use the Covid-19 vaccine AstraZeneca which is expected to be delivered in June, according to Baguio City administrator Bonifacio de la Peña.
This despite pronouncement of health authorities suspending the use of the vaccine to women 60 years old and below.
De la Peña said investigation on the reported side effects of the vaccine is still ongoing.
He added that they have not received reports of health workers experiencing severe side effects after getting inoculated.
De la Peña admitted though that fewer AstraZeneca vaccines were used compared to Sinovac.
Meanwhile, AstraZeneca assured the safety of its vaccine.
“On 7 April 2021, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) completed their assessment of extremely rare blood clotting events with low platelets from over 34 million people vaccinated with AstraZeneca's Covid-19 vaccines in the UK and EU. Overall, both of these reviews reaffirmed the vaccine offers a high-level of protection against all severities of Covid-19 and that these benefits continue to far outweigh the risks," AstraZeneca said in a statement.
Meanwhile, Benguet Governor Melchor Diclas said they are prepared on the possibility of the province being placed under enhanced community quarantine due to the rising Covid-19 cases.
At present, Benguet is under general community quarantine.
As of 12 p.m., 9 April, the province logged 13 new cases with five new Covid-related deaths.
There are a total confirmed cases of 6,383, 874 of which are active. The province also listed a total of 5,389 recoveries and 120 Covid-related deaths.
In Baguio City, there were 30 new cases and nine Covid-related deaths. The city has now 8,491 total, including 1,170 active cases. Baguio also listed a total of 7,163 recoveries and 158 Covid deaths.